Remote nurse support for HIV prevention medicines at pharmacies in Kenya
Tests remote nurse support for HIV prevention medicine at pharmacies, compared with usual care.
Plain-language title generated from the registry record
Registry title: TelePharm PrEP/PEP
Key facts
- Where
- Kisumu, KenyaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for clients aged 15 and older at risk for HIV who want to be screened for PrEP or PEP at a pharmacy in Kenya. It also involves pharmacies, pharmacists and remote nurses.
- Age
- Clients: 15 years or older. Pharmacists and remote nurses: 18 years or older.
- Sex
- All sexes can join.
Main reasons for not taking part
- Clients who will not give a phone number for surveys and study messages
- Clients currently enrolled in another HIV vaccine or prevention trial
- Clients with a medical condition that makes PrEP/PEP unsafe
- Clients with a condition that prevents informed consent or makes taking part unsafe
Read by machine on 9 November 2026.
Where in Kenya
- Kenya Medical Research InstituteKisumu, KenyaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fred Hutchinson Cancer Center
- Trial code
- NCT07561658
- Record updated
- 11 May 2026
- Original description
In this study, the investigators will evaluate whether introducing a remote nurse to screen, counsel, and guide clients through HIV self-testing (via a telehealth platform) and support interested clients (via SMS) between pharmacy visits increases PrEP/PEP initiations and continuation compared to standard PrEP/PEP delivery by pharmacy providers. The investigators hypothesize that pharmacy PrEP/PEP services delivered with telehealth support will result in better service utilization and implementation outcomes compared to standard delivery and be cost-effective to implement.Read full original descriptionShow less
Leveraging Telehealth to Optimize PrEP and PEP Delivery at Pharmacies in Kenya
In this study, the investigators will evaluate whether introducing a remote nurse to screen, counsel, and guide clients through HIV self-testing (via a telehealth platform) and support interested clients (via SMS) between pharmacy visits increases PrEP/PEP initiations and continuation compared to standard PrEP/PEP delivery by pharmacy providers. The investigators hypothesize that pharmacy PrEP/PEP services delivered with telehealth support will result in better service utilization and implementation outcomes compared to standard delivery and be cost-effective to implement.
Inclusion: Pharmacies; Registered with the Pharmacy and Poisons Board (PPB); Must have at least one full-time licensed pharmacist or pharmaceutical technologist on staff; Must have a private room where HIV testing and PrEP/PEP counseling can occur; >3 km from other study pharmacies; Willing to participate in research activities, including 2-day training for pharmacy providers; Willing to share pharmacy records with us; Sells HIVST kits that are WHO certified; Pharmacists/remote nurses; ≥ 18 years old; Licensed pharmacist, pharmaceutical technologist, or nurse; Willing to provide PrEP and PEP services, including HIV testing and associated counseling services; Willing to complete training on PEP/PrEP service delivery at pharmacies, including certification for rapid diagnostic testing; Able and willing to provide informed consent; Clients; ≥ 15 years old; Interested in being screened for PrEP or PEP; Meets all criteria to be eligible for pharmacy-delivered PrEP or PEP on the Prescribing Checklist, including being at risk for HIV and not having any medical conditions that might contraindicate PrEP/PEP safety; Able and willing to provide informed consent.
Exclusion: Currently enrolled in any other HIV vaccine or prevention trial; Have a condition that would preclude provision of informed consent, make study participation unsafe, complicate interpretation of outcome data, or otherwise interfere with achieving study objectives; Clients; Unwilling to provide a phone number at which an RA can reach them for completing surveys and communicate important study-related information.